Stock listing
Phio Pharmaceuticals Corp.
Selected listing: 44R1 · MUN · EUR · DE
Phio Pharmaceuticals Corp. (Munich:44R1), Health Technology. Latest release Oct 6, 2026: Phio Pharmaceuticals to Present at The Global Markets Virtual Forum…
- Ticker
- Munich:44R1
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
About Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (Ticker: PHIO) is a public company based in the United States, focusing on innovative therapies in the pharmaceutical sector. The company aims to provide effective treatment solutions through its proprietary technology platform.
Latest news from Phio Pharmaceuticals Corp.
Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026
October 5, 2026
Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
October 4, 2026
Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
October 5, 2026
Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference
September 23, 2026
Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma
September 14, 2026
Research Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. company profile
View the public company page for Phio Pharmaceuticals Corp. on 6ix.
Phio Pharmaceuticals Corp. news
Read company news and market updates connected to Phio Pharmaceuticals Corp..
Phio Pharmaceuticals Corp. investor events
Find investor webinars, events, and replay context for Phio Pharmaceuticals Corp..